These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12182942)

  • 1. Noncompetitive nature of oxytocin antagonists with general structure Mpa(1)Xxx(2)Sar(7)Arg(8).
    Havass J; Bakos K; Márki A; Gáspár R; Gera L; Stewart JM; Fülöp F; Tóth GK; Zupkó I; Falkay G
    Peptides; 2002 Aug; 23(8):1419-25. PubMed ID: 12182942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.
    Williams PD; Anderson PS; Ball RG; Bock MG; Carroll L; Chiu SH; Clineschmidt BV; Culberson JC; Erb JM; Evans BE
    J Med Chem; 1994 Mar; 37(5):565-71. PubMed ID: 8126695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the design of selective antagonists, potential tocolytics, and radioiodinated ligands for oxytocin receptors.
    Manning M; Cheng LL; Klis WA; Stoev S; Przybylski J; Bankowski K; Sawyer WH; Barberis C; Chan WY
    Adv Exp Med Biol; 1995; 395():559-83. PubMed ID: 8714021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban.
    Manning M; Miteva K; Pancheva S; Stoev S; Wo NC; Chan WY
    Int J Pept Protein Res; 1995; 46(3-4):244-52. PubMed ID: 8537178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of binding affinity of oxytocin antagonists to human and rat uterine oxytocin receptors and their correlation to the rat uterine oxytocic bioassay.
    Pak SC; Bertoncini D; Meyer W; Scaunas D; Flouret G; Wilson L
    Biol Reprod; 1994 Dec; 51(6):1140-4. PubMed ID: 7888492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of oxytocin antagonists for use in preterm labor.
    Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE
    Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M; Melin P; Maggi M
    Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of RU486 on estrogen, progesterone, oxytocin, and their receptors in the rat uterus during late gestation.
    Fang X; Wong S; Mitchell BF
    Endocrinology; 1997 Jul; 138(7):2763-8. PubMed ID: 9202215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
    Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis and in vitro receptor analysis of new potential oxytocin antagonists].
    Havass J; Bakos K; Tóth G; Fülöp F; Falkay G
    Acta Pharm Hung; 2000; 70(3-6):168-74. PubMed ID: 11379023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
    Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of an oxytocin antagonist, RWJ 22164 for treatment of preterm labor in laboratory models of uterine contractility.
    Demarest KT; Hahn DW; Ericson E; Capetola RJ; Fuchs AR; McGuire JL
    Am J Perinatol; 1989 Apr; 6(2):200-4. PubMed ID: 2712917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin antagonist (dTVT) and oxytocin receptors in myometrium and decidua.
    Fuchs AR; Vangsted A; Ivanisevic M; Demarest K
    Am J Perinatol; 1989 Apr; 6(2):205-8. PubMed ID: 2540761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
    Reinheimer TM; Bee WH; Resendez JC; Meyer JK; Haluska GJ; Chellman GJ
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2275-81. PubMed ID: 15671092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin antagonists in preterm labour and delivery.
    Melin P
    Baillieres Clin Obstet Gynaecol; 1993 Sep; 7(3):577-600. PubMed ID: 8252818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterus-targeted liposomes for preterm labor management: studies in pregnant mice.
    Refuerzo JS; Leonard F; Bulayeva N; Gorenstein D; Chiossi G; Ontiveros A; Longo M; Godin B
    Sci Rep; 2016 Oct; 6():34710. PubMed ID: 27725717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
    Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.